Post Categories
Are the New COVID Boosters Better Than the Old Boosters?
November 2, 2022
This fall, the FDA approved the rollout of two updated Omicron-specific COVID-19 boosters. These new COVID boosters aim to provide more protection against the…
Research Reveals a Fungi-Cancer Connection, with Potential Diagnostic Implications
October 31, 2022
Like bacteria, fungal microorganisms are an important part of the human microbiome and essential to human health. Scientists studying the microbiome over the past…
Can Nasal Vaccines Confer Sterilizing Immunity?
October 26, 2022
A COVID-19 vaccine that provides sterilizing immunity may be in our future – and with it, a potential light at the end of the…
Evaluating the Costs and Benefits of COVID Lockdowns
October 24, 2022
In the wake of the economic and human costs of the COVID-19 pandemic and governments’ responses to the virus, researchers have tried to evaluate…
FDA Sanctions First Interchangeable Biosimilar Sans Switching Study
October 17, 2022
In August 2022, the Food and Drug Administration (FDA) approved Cimerli™ (ranibizumab-eqrn) as a biosimilar for Lucentis® (ranibizumab). In a time when high prescription…
Amid Polio Outbreaks Around the World, Public Health Leaders Continue to Sound the Alarm
October 10, 2022
“Polio anywhere is a risk to people everywhere.” This public health mantra gets to the root of the problem. Polio remains endemic in Afghanistan…
Lymphatic Delivery Offers Potential Perks for Kinase Inhibitors and Other Cancer Drugs
October 3, 2022
A potential new cancer drug delivery method — through the gut’s lymphatic system rather than blood vessels — could improve treatment outcomes and reduce…
Burden of Disease by Social Status
September 28, 2022
Inequality in the United States has never been more apparent, especially in the wake of the COVID-19 pandemic. In a time when higher income…
Robotic Jumper Scales Tall Buildings in a Single Bound
September 26, 2022
Not unlike a superhero leaping into the air to protect humanity, a new jumping robot can reach a height of 30 meters (100 feet),…
More Simple Rabies Test Could Reduce Rabies Deaths
September 21, 2022
According to the Centers for Disease Control and Prevention (CDC), the rabies virus leads to an estimated 59,000 human deaths globally each year. This…
It Took Time, But Ionis Made Antisense Therapy Make Sense
September 19, 2022
Although antisense therapy — using antisense oligonucleotides (ASOs) to control protein function — has generated controversy and skepticism over the years, it is now…
Holding Out Hope for a Deal on Long-Lasting HIV Prevention Drug
September 11, 2022
Although a new injectable anti-HIV drug, cabotegravir, could be instrumental in drastically reducing the spread of disease, its price tag may render the drug…
EU Clinical Trial Regulation 536/2014 and CTIS: Common Questions and Answers
March 20, 2024
As reported in our previous CTIS-related blog post, the way clinical trials are documented in the European Union (EU) is changing. By January 31,…
Customized Therapies Offer Hope for Patients with Ultra-Rare Genetic Diseases
March 18, 2024
Leveraging rapid developments in gene therapy, researchers are designing new ways to target ultra-rare genetic diseases with treatments tailored to a patient’s specific genetic…
Navigating Changes to EU Clinical Trial Management: What You Need to Know
March 13, 2024
The face of clinical trials in the European Union (EU) is changing. By January 31, 2025, all ongoing clinical trials must move to the…
Psychoactive Drug Ibogaine Has Transformative Effects for Veterans with Traumatic Brain Injury
March 11, 2024
Traumatic brain injuries (TBIs), commonly experienced by military personnel, often incur deep damage and invisible scars. Such injuries are significant contributors to post-traumatic stress…
The Link Between Obesity Drugs and Brain Health
March 6, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists are arguably the hottest topic in medical innovation. The drugs semaglutide and tirzepatide, known under brand names like Ozempic,…
Advances in Treating Autoimmune Diseases Focus on Restoring Immune Tolerance
March 4, 2024
For decades, the battle against autoimmune diseases like type 1 diabetes, lupus, and multiple sclerosis has been an uphill struggle. Conventional treatments most often…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
